SCHEMBL869246

SCHEMBL869246

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc(CCNC(=O)OCc2ccccc2)c2occ(-c3ccc4c(c3)CCN4C(=O)Cc3cc(F)ccc3F)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF2AK3 Q9NZJ5 16/20 0.48
RIPK1 Q13546 3/20 0.35
EIF2AK1 Q9BQI3 2/20 0.34
MAPK13 O15264 1/20 0.33
ABL1 P00519 1/20 0.33
NTRK1 P04629 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
YES1 P07947 1/20 0.33
LYN P07948 1/20 0.33
RET P07949 1/20 0.33
MET P08581 1/20 0.33
HCK P08631 1/20 0.33
FGR P09769 1/20 0.33
KIT P10721 1/20 0.33
FGFR1 P11362 1/20 0.33
SRC P12931 1/20 0.33
FLT1 P17948 1/20 0.33
EIF2AK2 P19525 1/20 0.33
EPHA2 P29317 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14655779 0.93 EIF2AK3 (0.51) EIF2AK3RIPK1EIF2AK1LCKEIF2AK2
SCHEMBL6926794 0.87 EIF2AK3 (0.60) EIF2AK3RIPK1EIF2AK1LCKEIF2AK2
SCHEMBL869492 0.83 EIF2AK3 (0.56) EIF2AK3RIPK1EIF2AK1MAPK13ABL1
SCHEMBL869093 0.82 EIF2AK3 (0.55) EIF2AK3RIPK1EIF2AK2
SCHEMBL14576841 0.77 EIF2AK3 (0.67) EIF2AK3RIPK1EIF2AK1LCKEIF2AK2
SCHEMBL14655630 0.75 EIF2AK3 (0.61) EIF2AK3EIF2AK1EIF2AK2CYP11B1CYP11B2
SCHEMBL869247 0.75 EIF2AK3 (0.39) EIF2AK3RIPK1EIF2AK1CYP11B1CYP11B2
SCHEMBL868362 0.75 EIF2AK3 (0.63) EIF2AK3RIPK1EIF2AK1LCKEIF2AK2
SCHEMBL14655668 0.74 EIF2AK3 (0.60) EIF2AK3RIPK1EIF2AK1CYP11B1CYP11B2
SCHEMBL868994 0.73 EIF2AK3 (0.73) EIF2AK3RIPK1EIF2AK1LCKEIF2AK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2549868-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-01-07 EP disclosed
US-8598156-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2013-12-03 US disclosed
US-20130018038-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2013-01-17 US disclosed
US-20120077828-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018038-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R EIF2AK3 16/4885RIPK1 218/4885EIF2AK1 20/4885
US-20120077828-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R EIF2AK3 16/4885RIPK1 218/4885EIF2AK1 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.